Impact of Heart Allocation Change on Selection and Adverse Events of Bridged‐To‐Transplant Durable Ventricular Assist Device Recipients

Despite a more significant comorbidity burden, patients who were supported with an LVAD as BTT after the allocation change were less likely to be re-hospitalized or have device-related adverse events.